Details
Ursofalc Indications
lysis-cholesterol calculi in the gall-bladder (not more than 15 mm in diameter, rentgennegativnyh provided functioning gall bladder); gastritis caused by bile reflux; symptomatic treatment of primary biliary cirrhosis phase compensation.
Contradictions
hypersensitivity to any component of the drug;
acute inflammation of the gallbladder or biliary tract;
obstruction of the biliary tract (common bile duct or duct bladder);
Dosage & Administration
The daily dose is adjusted depending on the indication.
For lysis of cholesterol stones in the gallbladder
The dose corresponding to about 10 mg / kg of body weight, body weight is at:
<60 kg - 2 capsules;
61-80 kg - 3 capsules;
81-100 kg - 4 capsules;
>101 kg - 5 capsules.
The capsules should be taken with liquid, in the evening, before going to bed, with a small amount of liquid. The drug should be carried out regularly. The required duration of application can make 6-24 months. Unless noted, continuation of therapy is inappropriate, after 12 months of application of the size reduction of the drug stones. The effectiveness of treatment is monitored by ultrasound or X-ray every 6 months. With the development of calcification of stones treatment ceased.
For the treatment of reflux gastritis
1 capsule of Ursofalk 250 mg 1 time per day with an amount of liquid in the evening before bedtime.
Assign, usually within 10-14 days. The decision on the duration of the drug taken individually.
For the symptomatic treatment of primary biliary cirrhosis
The daily dose depends on the body weight and is 3-7 capsules (about 14 ± 2 mg of ursodeoxycholic acid per 1 kg of body weight).
